Recommendations have been made to standardize patient outcome analysis (PRO) in randomized controlled trials (RCTs) involving patients with cancer to ensure that quality of life outcomes reflect real risks, benefits and tolerability of a given treatment, notes an international consortium of experts. “The use of patient reported results in cancerContinue Reading